News
Novo Nordisk teams with telehealth firms Hims, Ro to sell Wegovy at lower price
Novo Nordisk A/S said it would sell its popular weight-loss drug Wegovy for a steeply reduced price on several telehealth platforms. The strategy comes as rival Eli Lilly & Co. is working with telehealth firms to distribute lower-cost vials of its own obesity medication,
Since launching its wildly popular weight-loss drug Wegovy in 2021, Novo Nordisk has raised its annual sales guidance several ...
A judge denied compounders' request to keep making off-brand Wegovy and Ozempic after the FDA removed semaglutide from its shortage list.
Compounded versions of Novo Nordisk’s Wegovy and Ozempic will need ... The trade group’s chairman, Lee Rosebush, told Reuters that the association presented additional evidence of an ongoing ...
Novo Holdings, the controlling shareholder of obesity drugmaker Novo Nordisk , nearly doubled annual income and investment ...
Despite the decision being a win for Novo Nordisk, the compounded drugs sector is far too complex for this to be a final ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback